InvestorsHub Logo
Followers 3
Posts 190
Boards Moderated 0
Alias Born 05/16/2013

Re: None

Monday, 11/18/2019 11:27:31 AM

Monday, November 18, 2019 11:27:31 AM

Post# of 430368
I am impressed by the technology used in EVAPORATE to distinguish different kinds / qualities of plaque. Didn’t JT mention the improved testing capabilities over CHERRY study? Regardless, even a significant slowing of plaque progression is a big plus, in my book. If you sold today, you lost out on a lot of upside. Then again, I don’t trade, I invest.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News